补阳还五汤联合骨髓间充质干细胞移植 对脊髓损伤气虚血瘀证的疗效

目的：探讨补阳还五汤（BYHWD）联合骨髓间充质干细胞（BMSCs）移植对脊髓损伤（SCI）气虚血瘀 证的疗效，并探讨其分子机制。方法：将120只雄性SD大鼠随机分为5组：对照组、气虚血瘀组、BYHWD 组、BMSCs组、BYHWD+BMSCs组，每组24只。制作SCI气虚血瘀证复合动物模型，并分别予以BYHWD、 BMSCs或BYHWD+BMSCs治疗28 d。治疗前、治疗后1 d、14 d、28 d通过自发性直立探究行为观察前肢运 动功能恢复情况；治疗后28 d，ELISA法检测脊髓损伤局部cAMP浓度，HE染色观察损伤局部轴突形态，免 疫组织化学法检测脊髓损伤局部RhoA、神经生长因子（NGF）、脑源性神经营养因子（BDNF）的表达。结 果：治疗后，BYHWD 组、BMSCs 组和 BYHWD+BMSCs 组大鼠的前肢使用率均高于气虚血瘀组，脊髓 cAMP 含量均高于气虚血瘀组（均 P＜0.01），且 BYHWD+BMSCs 组高于 BYHWD 组和 BMSCs 组（均 P＜ 0.05 或 P＜0.01）。HE 染色显示气虚血瘀组、BMSCs 组脊髓右后外侧索轴突水肿或缺失，髓鞘排列散乱； BYHWD组、BYHWD+BMSCs组脊髓损伤程度减轻。与气虚血瘀组相比，BYHWD组、BYHWD+BMSCs组 NGF、BDNF阳性表达升高，BMSCs组BDNF阳性表达升高，RhoA表达下降（P＜0.05或P＜0.01）；且BYHWD+BMSCs组BDNF表达水平高于BYHWD组和BMSCs组（P＜0.05），RhoA表达水平低于BYHWD组和 BMSCs组（P＜0.05）。结论：BYHWD联合BMSCs移植对保护SCI气虚血瘀证脊髓局部轴突、改善前肢运 动功能可产生协同增效作用，其作用机制可能与上调脊髓局部微环境cAMP浓度，抑制RhoA表达，上调 NGF、BDNF有关。     

贺菊乔教授运用脉管通汤治疗下肢血管疾病验案举隅

贺菊乔,湖南中医药大学第一附属医院主任医师,教授,博士研究生导师,湖南省名中医,第五批全国老中医药专家学术经验继承工作指导老师。擅长各种外科疾病的诊治,衷中参西,学验俱丰,在周围血管病的诊治方面也有较深研究和造诣,疗效卓著。笔者作为贺菊乔名老中医药专家传承工作室课题组负责人跟师侍诊,学有所获,本文就贺菊乔教授运用自拟方脉管通汤治疗下肢血管疾病的经验介绍如下。1血栓性深静脉炎案     

巧食薏仁治小病

正薏仁是常见的药食同源食物,有多种保健治病的功效,一般人群均可食用,尤其适宜多湿地区及关节炎、肢体浮肿、脚气病、肥胖等人群。推荐薏仁的4个小验方,帮您祛病健体。病后调理——薏仁红枣小米粥验方:取薏仁、红枣、小米各50克,加水煮成粥,空腹食用,每日1次。病后术后,人体较为虚弱,应该调养身体、适当滋补。俗话说"药补不如食补",食物中的营养素更容易被人体消化吸收,应先以流质或半流质的食物来调理脾胃,再逐     

矾冰纳米乳调二味拔毒散治疗带状疱疹的临床观察

目的:探讨矾冰纳米乳调二味拔毒散治疗带状疱疹的临床疗效。方法:将100例病人随机分为治疗组和对照组,各50例,治疗组予以矾冰纳米乳调二味拔毒散外敷,对照组予喷昔洛韦乳膏外涂。结果:治疗组在临床疗效、治疗后3 d、7 d的疼痛程度评分及止痛、皮损结痂时间均优于对照组,两组比较有统计学意义(P<0.05)。结论:矾冰纳米乳调二味拔毒散治疗带状疱疹疗效确切,能有效缓解病人的疼痛。     

PI3K/Akt信号通路对人结肠癌HT-29细胞增殖的影响

目的探讨PI3K/Akt信号通路在人结肠癌HT-29细胞增殖中的作用。方法人结肠癌HT-29细胞分为结肠癌组和抑制剂组,癌旁正常细胞株为对照组,均取对数生长期细胞进行实验。结肠癌组和对照组应用培养基+等量生理盐水进行培养,抑制剂组应用培养基+PI3K/Akt信号通抑制剂LY294002 10μL进行培养。MTT法检测3组培养24、48、72h时细胞增殖情况,Western blot法检测3组PI3K、Akt、磷酸化Akt、P-糖蛋白表达,流式细胞仪检测3组细胞周期及凋亡情况。结果培养24、48、72h,对照组和抑制剂组细胞吸光度值均小于结肠癌组(P0.05),对照组与抑制剂组比较差异无统计学意义(P0.05);培养24h,对照组和抑制剂组PI3K、Akt、磷酸化Akt和P-糖蛋白表达均低于结肠癌组(P0.05),对照组与抑制剂组比较差异无统计学意义(P0.05);流式细胞仪检测结果显示,结肠癌组G_1期细胞比率[(62.54±5.15)%]、细胞凋亡率[(45.18±6.76)%]均高于对照组[(39.47±3.84)%、(10.98±0.62)%]和抑制剂组[(37.18±2.03)%、(9.31±0.41)%](P0.05),G_2/M期细胞比率[(11.34±2.06)%]低于对照组[(29.32±3.77)%]和抑制剂组[(28.71±2.35)%](P0.05),S期细胞比率[(26.75±2.46)%]与对照组[(29.81±3.18)%]和抑制剂组[(30.44±2.87)%]比较差异均无统计学意义(P0.05);抑制剂组G_1期、G_2/M期、S期细胞比率及细胞凋亡率与对照组比较差异均无统计学意义(P0.05)。结论 PI3K/Akt信号通路可抑制人结肠癌HT-29细胞增殖,其机制可能与抑制其转导通路下游P-糖蛋白表达、使细胞周期阻滞于G_1期有关。     

复方黄甘颗粒治疗复发性生殖器疱疹45例疗效观察

目的：观察中药复方黄甘颗粒对复发性生殖器疱疹的临床疗效。方法：将90例复发性生殖器疱疹患者按随机数字表法分为治疗组和对照组各45例,治疗组服用复方黄甘颗粒（1包,Bid）,对照组服用泛昔洛韦片（0.25g,Tid）,30d为一个疗程。治疗结束后对两组患者的临床疗效进行比较。结果：近期疗效治疗组与对照组相当（P〉0.05）,抗复发疗效治疗组优于对照组（P〈0.05）。结论：中药复方黄甘颗粒对生殖器疱疹抗复发疗效显著。     

慢性非细菌性前列腺炎/慢性盆腔疼痛综合征患者前列腺液中炎症因子差异表达的临床意义

Objective To investigate the role of inflammatory cytokines in the pathogenesis of chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CAP/CPPS) patients. Methods The 38 cases with CAP/CPPS patients (18 cases of CAP and 20 cases of CPPS) and 20 cases of healthy controls were selected. The differential expressions of 40 kinds of inflammatory cytokines were detec-ted by antibody arrays in prostate fluid. Results The inflammatory cytokines which increased more than 1.5 times expression have been found. There were seven kinds in CAP including monocyte che-moattractant protein (MCP)-1, solution tumor necrosis factor receptor Ⅱ(s TNF R Ⅱ), platelet-de-rived growth faetor-BB (PDGF-BB), interleukin (IL)-β, IL-11、IL-6、MCP-2 and five kinds in CPPS groups including MCP-1、PDGF-BB、MCP-2、s TNF R Ⅱ、It-11 respectively, compared with healthy control group. The cluster analysis results showed that protein expression of Monocyte chemoattrac-tant protein 1 (MCP-1)and platelet-derived growth factor BB (PDGF-BB) were significantly increased in CAP (3.47 and 2.07 times) and CPPS (2.25 and 2.19 times) compared with healthy control group and were the final polymerization of inflammatory cytokines. The protein expression of interleukin 1 β (IL-1 β), MCP-1 and soluble tumor necrosis factor Ⅱ (s TNF R Ⅱ) in CAP group was increased more than 1.85,1.55,1.67 times compared with CPPS group. Conclusions Elevated expression of inflammatory cytokines may play an important role in the course of CAP/CPPS disease. The extent of the inflammatory response of CAP was higher than CPPS. The inflammatory factors of MCP-1 and PDGF-BB could serve as a novel diagnostic marker.     

慢性非细菌性前列腺炎/慢性盆腔疼痛综合征患者前列腺液中炎症因子差异表达的临床意义

Objective To investigate the role of inflammatory cytokines in the pathogenesis of chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CAP/CPPS) patients. Methods The 38 cases with CAP/CPPS patients (18 cases of CAP and 20 cases of CPPS) and 20 cases of healthy controls were selected. The differential expressions of 40 kinds of inflammatory cytokines were detec-ted by antibody arrays in prostate fluid. Results The inflammatory cytokines which increased more than 1.5 times expression have been found. There were seven kinds in CAP including monocyte che-moattractant protein (MCP)-1, solution tumor necrosis factor receptor Ⅱ(s TNF R Ⅱ), platelet-de-rived growth faetor-BB (PDGF-BB), interleukin (IL)-β, IL-11、IL-6、MCP-2 and five kinds in CPPS groups including MCP-1、PDGF-BB、MCP-2、s TNF R Ⅱ、It-11 respectively, compared with healthy control group. The cluster analysis results showed that protein expression of Monocyte chemoattrac-tant protein 1 (MCP-1)and platelet-derived growth factor BB (PDGF-BB) were significantly increased in CAP (3.47 and 2.07 times) and CPPS (2.25 and 2.19 times) compared with healthy control group and were the final polymerization of inflammatory cytokines. The protein expression of interleukin 1 β (IL-1 β), MCP-1 and soluble tumor necrosis factor Ⅱ (s TNF R Ⅱ) in CAP group was increased more than 1.85,1.55,1.67 times compared with CPPS group. Conclusions Elevated expression of inflammatory cytokines may play an important role in the course of CAP/CPPS disease. The extent of the inflammatory response of CAP was higher than CPPS. The inflammatory factors of MCP-1 and PDGF-BB could serve as a novel diagnostic marker.     

乳增宁贴膏外贴治疗乳腺增生病的临床研究

目的：观察乳增宁贴膏外贴治疗乳腺增生病的临床疗效。方法：将所选乳腺增生病病例随机分为乳增宁贴膏外贴治疗组30例和散结止痛膏外贴对照组30例。观察两组治疗前后乳房肿块大小及疼痛程度的变化，以及治疗前后患者黄体期性激素水平变化。结果：两组病例的年龄、病情轻重、病程等一般临床资料无显著性差异（P〉0．05）。治疗1个疗程后，两组治疗后乳房疼痛、肿块硬度、肿块直径等临床症状明显改善，但治疗组临床症状改善更明显（P〈0．01），肿块分布范围无明显改善。治疗组升高P值含量，降低E2、PRL值含量方面优于对照组（P〈0．01）。结论：乳增宁贴膏外贴治疗乳腺增生病具有较好疗效，其机理可能与改善乳房部血液循环，促进包块吸收和调节机体内分泌有关。     

慢性非细菌性前列腺炎/慢性盆腔疼痛综合征患者前列腺液中炎症因子差异表达的临床意义

Objective To investigate the role of inflammatory cytokines in the pathogenesis of chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CAP/CPPS) patients. Methods The 38 cases with CAP/CPPS patients (18 cases of CAP and 20 cases of CPPS) and 20 cases of healthy controls were selected. The differential expressions of 40 kinds of inflammatory cytokines were detec-ted by antibody arrays in prostate fluid. Results The inflammatory cytokines which increased more than 1.5 times expression have been found. There were seven kinds in CAP including monocyte che-moattractant protein (MCP)-1, solution tumor necrosis factor receptor Ⅱ(s TNF R Ⅱ), platelet-de-rived growth faetor-BB (PDGF-BB), interleukin (IL)-β, IL-11、IL-6、MCP-2 and five kinds in CPPS groups including MCP-1、PDGF-BB、MCP-2、s TNF R Ⅱ、It-11 respectively, compared with healthy control group. The cluster analysis results showed that protein expression of Monocyte chemoattrac-tant protein 1 (MCP-1)and platelet-derived growth factor BB (PDGF-BB) were significantly increased in CAP (3.47 and 2.07 times) and CPPS (2.25 and 2.19 times) compared with healthy control group and were the final polymerization of inflammatory cytokines. The protein expression of interleukin 1 β (IL-1 β), MCP-1 and soluble tumor necrosis factor Ⅱ (s TNF R Ⅱ) in CAP group was increased more than 1.85,1.55,1.67 times compared with CPPS group. Conclusions Elevated expression of inflammatory cytokines may play an important role in the course of CAP/CPPS disease. The extent of the inflammatory response of CAP was higher than CPPS. The inflammatory factors of MCP-1 and PDGF-BB could serve as a novel diagnostic marker.